(Google indeed became one of the company’s first backers. Brin and Wojcicki divorced in 2015.) The 23andMe test captured the ...

“Early on she would joke that 23andMe is going to be way bigger than Google,” Avey said. Wojcicki wanted to make her own name ...

The struggling genetic-testing company 23andMe has been quietly exploring a possible sale of its telehealth offering, Business Insider has learned. 23andMe has been testing the waters for a buyer ...

At-home DNA testing is no longer in high demand — and critics have raised concerns about unreliable tests and privacy.

But technology can make a difference in combating the virus' spread. For one, Apple and Google are teaming up to build a contact-tracing feature for their phones, which would use Bluetooth to ...

But there are facts, law and precedent on point, which are worth examining. First, we can start with 23andMe’s privacy statement, which is—to their credit—strong. In general, data can be ...

When evaluating 23andMe's stock performance and future outlook, investors should consider short-term market trends and long-term growth potential. This analysis will dive into recent stock metrics ...

23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and ...

The data watchdogs of the UK and Canada will investigate genetic testing company 23andMe over a data breach in October 2023. Hackers gained access to personal information of 6.9 million people ...

Want to know more about your ancestry and heritage? In this year’s best Black Friday deals, DNA genetic testing kits from 23andMe are now 50% off, so shoppers can get insights into their health ...

23andMe has been exploring a possible sale of its telehealth business, Business Insider has learned. The struggling health company bought the virtual-care startup Lemonaid in 2021 for $400 million ...

23andMe's stock plummeted after a 2023 data breach exposed millions of customer accounts. The struggling genetic-testing company 23andMe has been quietly exploring a possible sale of its ...